Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
8.52
+0.86 (11.23%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Aardvark Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Aardvark Therapeutics stock have an average target of 31.5, with a low estimate of 21 and a high estimate of 50. The average target predicts an increase of 269.72% from the current stock price of 8.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aardvark Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 3 | 3 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +146.48% | Apr 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +486.85% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +205.16% | Mar 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +146.48% | Mar 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +486.85% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
n/a
from 20.49M
Revenue Next Year
n/a
EPS This Year
-2.68
from -5.15
EPS Next Year
-2.62
from -2.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | 3.2M | 42.0M |
| Avg | n/a | 765,000 | 20.5M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 5,390.2% |
| Avg | - | - | 2,578.7% |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.65 | -2.47 | -1.85 |
| Avg | -2.68 | -2.62 | -2.98 |
| Low | -3.49 | -2.96 | -3.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.